<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37879951</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1000-0607</ISSN><JournalIssue CitedMedium="Print"><Volume>48</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>25</Day></PubDate></JournalIssue><Title>Zhen ci yan jiu = Acupuncture research</Title><ISOAbbreviation>Zhen Ci Yan Jiu</ISOAbbreviation></Journal><ArticleTitle>Effect of electroacupuncture intervention on the spinal cord PPIA/NF-&#x3ba;B signaling pathway in mice with amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>1009</StartPage><EndPage>1016</EndPage><MedlinePgn>1009-1016</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.13702/j.1000-0607.20230251</ELocationID><ELocationID EIdType="pii" ValidYN="Y">1000-0607(2023)10-1009-08</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To observe the effects of electroacupuncture (EA) on motor function, expression of extracellular cyclophile A(PPIA) and PPIA/nuclear factor-&#x3ba;B (NF-&#x3ba;B) signaling pathway in spinal cord of amyotrophic la-teral sclerosis (ALS) mice, so as to explore the mechanism of EA intervention in regulating extracellular PPIA on neuroinflammation in ALS mice.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Thirty ALS-SOD1<sup>G93A</sup> mice with hSOD1-G93A gene were randomly divided into model, EA and Riluzole groups , with 10 mice in each group, and other 10 ALS-SOD1<sup>G93A</sup> negative mice were used as the blank group. EA was applied to bilateral "Yanglingquan"(GB34) and "Zusanli"(ST36) for 20 min once daily, 5 days a week for 2 weeks. In the Riluzole group, riluzole solution (30 mg&#xb7;kg<sup>-1</sup>&#xb7;d<sup>-1</sup>) was administrated intragastrically, and the treatment time was the same as that in the EA group.Rotating rod experiment and open field experiment were used to evaluate the changes in motor function of mice .The morphology of motor neurons in the anterior horn of spinal cord was observed by HE staining.The relative protein expression levels of PPIA, TDP-43 and NF-&#x3ba;B in the spinal cord were detected by Western blot.The positive expression level of TDP-43 in the spinal cord was detected by immunohistochemistry. The positive expression level of PPIA in spinal cord was marked by immunofluorescence. Serum PPIA content was determined by ELISA.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Compared with the blank group, the time of rod dropping and the total distance of open field movement in the model group were shortened (<i>P</i>&lt;0.01), the number of motor neurons in the anterior horn of the spinal cord was reduced, the cell morphology was incomplete, the cell body was atrophied, the protein expression and positive expression of TDP-43 were increased (<i>P</i>&lt;0.01), the protein expressions of PPIA and NF-&#x3ba;B in the spinal cord were increased(<i>P</i>&lt;0.01), the serum content of PPIA and immunofluorescence expression of PPIA in spinal cord were increased (<i>P</i>&lt;0.01). Compared with the model group, the time of rod dropping and the total distance of open field movement of mice in the EA group and the Riluzole group were prolonged (<i>P</i>&lt;0.05, <i>P</i>&lt;0.01), and the injury of motor neuron in the anterior horn of the spinal cord was decreased, the protein expression and positive expression of TDP-43 in the spinal cord were decreased (<i>P</i>&lt;0.05, <i>P</i>&lt;0.01)&#xff1b;the relative expression levels of PPIA and NF-&#x3ba;B proteins were decreased (<i>P</i>&lt;0.05, <i>P</i>&lt;0.01), and the content of PPIA in serum and the immunofluorescence expression of PPIA in the spinal cord were decreased (<i>P</i>&lt;0.05, <i>P</i>&lt;0.01) in the EA group&#xff1b;the relative protein expression of NF-&#x3ba;B and fluorescence expression of PPIA in spinal cord of mice in the Riluzole group were decreased (<i>P</i>&lt;0.05).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">EA intervention can improve motor function in ALS mice, and its mechanism may be related to the inhibition of PPIA/NF-&#x3ba;B signaling pathway by EA to alleviating neuroinflammatory response.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jun-Yang</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>College of Acupuncture and Tuina, (, Xianyang 712046, Shaanxi Province). 1229236085@qq.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Yuan-Rong</ForeName><Initials>YR</Initials><AffiliationInfo><Affiliation>The Second Clinical Medical College, Shaanxi University of Chinese Medicine, Xianyang 712046, Shaanxi Province, China, (, Xianyang 712046, Shaanxi Province).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Second Clinical Medical College, Shaanxi University of Chinese Medicine, Xianyang 712046, Shaanxi Province, China, (, Xianyang 712046, Shaanxi Province).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Hua</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>College of Acupuncture and Tuina, (, Xianyang 712046, Shaanxi Province).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>College of Acupuncture and Tuina, (, Xianyang 712046, Shaanxi Province).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shaanxi Provincial Key Laboratory of Combination of Acupuncture and Medicine, Xianyang 712046, Shaanxi Province), (, Xianyang 712046, Shaanxi Province.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Ying-Qian</ForeName><Initials>YQ</Initials><AffiliationInfo><Affiliation>College of Acupuncture and Tuina, (, Xianyang 712046, Shaanxi Province).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shaanxi Provincial Key Laboratory of Combination of Acupuncture and Medicine, Xianyang 712046, Shaanxi Province), (, Xianyang 712046, Shaanxi Province.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>College of Acupuncture and Tuina, (, Xianyang 712046, Shaanxi Province).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shaanxi Provincial Key Laboratory of Combination of Acupuncture and Medicine, Xianyang 712046, Shaanxi Province), (, Xianyang 712046, Shaanxi Province.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qiang</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>College of Acupuncture and Tuina, (, Xianyang 712046, Shaanxi Province). 1107683030@qq.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shaanxi Provincial Key Laboratory of Combination of Acupuncture and Medicine, Xianyang 712046, Shaanxi Province), (, Xianyang 712046, Shaanxi Province. 1107683030@qq.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>chi</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>&#x7535;&#x9488;&#x5bf9;&#x808c;&#x840e;&#x7f29;&#x4fa7;&#x7d22;&#x786c;&#x5316;&#x75c7;&#x5c0f;&#x9f20;&#x810a;&#x9ad3;PPIA/NF-&#x3ba;B&#x4fe1;&#x53f7;&#x901a;&#x8def;&#x7684;&#x5f71;&#x54cd;.</VernacularTitle></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Zhen Ci Yan Jiu</MedlineTA><NlmUniqueID>8507710</NlmUniqueID><ISSNLinking>1000-0607</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>7LJ087RS6F</RegistryNumber><NameOfSubstance UI="D019782">Riluzole</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015671" MajorTopicYN="Y">Electroacupuncture</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019782" MajorTopicYN="N">Riluzole</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="chi"><AbstractText><b>&#x76ee;&#x7684;</b>: &#x89c2;&#x5bdf;&#x7535;&#x9488;&#x5bf9;&#x808c;&#x840e;&#x7f29;&#x4fa7;&#x7d22;&#x786c;&#x5316;&#x75c7;&#xff08;ALS&#xff09;&#x5c0f;&#x9f20;&#x53d1;&#x75c5;&#x671f;&#x8fd0;&#x52a8;&#x529f;&#x80fd;&#x3001;&#x810a;&#x9ad3;&#x7ec6;&#x80de;&#x5916;&#x4eb2;&#x73af;&#x7d20;A&#xff08;PPIA&#xff09;&#x53ca;PPIA/&#x6838;&#x56e0;&#x5b50;&#xff08;NF&#xff09;-&#x3ba;B&#x4fe1;&#x53f7;&#x901a;&#x8def;&#x76f8;&#x5173;&#x86cb;&#x767d;&#x8868;&#x8fbe;&#x7684;&#x5f71;&#x54cd;&#xff0c;&#x63a2;&#x8ba8;&#x7535;&#x9488;&#x5e72;&#x9884;&#x8c03;&#x8282;&#x7ec6;&#x80de;&#x5916;PPIA&#x5bf9;ALS&#x5c0f;&#x9f20;&#x795e;&#x7ecf;&#x708e;&#x6027;&#x7684;&#x4f5c;&#x7528;&#x673a;&#x5236;&#x3002;<b>&#x65b9;&#x6cd5;</b>: &#x94dc;&#x950c;&#x8d85;&#x6c27;&#x5316;&#x7269;&#x6b67;&#x5316;&#x9176;1&#xff08;SOD1&#xff09;<sup>G93A</sup>&#x5c0f;&#x9f20;&#x6309;&#x968f;&#x673a;&#x6570;&#x5b57;&#x8868;&#x6cd5;&#x5206;&#x4e3a;&#x6a21;&#x578b;&#x7ec4;&#x3001;&#x7535;&#x9488;&#x7ec4;&#x3001;&#x5229;&#x9c81;&#x5511;&#x7ec4;&#xff0c;&#x540c;&#x7a9d;SOD1<sup>G93A</sup>&#x9634;&#x6027;&#x5c0f;&#x9f20;&#x4f5c;&#x4e3a;&#x7a7a;&#x767d;&#x7ec4;&#xff0c;&#x6bcf;&#x7ec4;10&#x53ea;&#x3002;&#x7535;&#x9488;&#x7ec4;&#x7535;&#x9488;&#x53cc;&#x4fa7;&#x201c;&#x9633;&#x9675;&#x6cc9;&#x201d;&#x201c;&#x8db3;&#x4e09;&#x91cc;&#x201d;&#xff0c;&#x6bcf;&#x6b21;20 min&#xff0c;&#x6bcf;&#x65e5;1&#x6b21;&#xff0c;&#x6bcf;&#x5468;&#x6cbb;&#x7597;5 d&#xff0c;&#x5171;&#x6cbb;&#x7597;2&#x5468;&#x3002;&#x5229;&#x9c81;&#x5511;&#x7ec4;&#x5c0f;&#x9f20;&#x6309;&#x7167;30 mg&#xb7;kg<sup>-1</sup>&#xb7;d<sup>-1</sup>&#x7684;&#x5242;&#x91cf;&#x4e88;&#x5229;&#x9c81;&#x5511;&#x704c;&#x80c3;&#xff0c;&#x6cbb;&#x7597;&#x65f6;&#x95f4;&#x4e0e;&#x7535;&#x9488;&#x7ec4;&#x4e00;&#x81f4;&#x3002;&#x91c7;&#x7528;&#x8f6c;&#x68d2;&#x5b9e;&#x9a8c;&#x548c;&#x65f7;&#x573a;&#x5b9e;&#x9a8c;&#x8bc4;&#x4ef7;&#x5404;&#x7ec4;&#x5c0f;&#x9f20;&#x8fd0;&#x52a8;&#x529f;&#x80fd;&#x7684;&#x53d8;&#x5316;&#xff1b;HE&#x67d3;&#x8272;&#x6cd5;&#x89c2;&#x5bdf;&#x5404;&#x7ec4;&#x5c0f;&#x9f20;&#x810a;&#x9ad3;&#x524d;&#x89d2;&#x8fd0;&#x52a8;&#x795e;&#x7ecf;&#x5143;&#x5f62;&#x6001;&#xff1b;Western blot&#x6cd5;&#x68c0;&#x6d4b;&#x5404;&#x7ec4;&#x5c0f;&#x9f20;&#x810a;&#x9ad3;&#x7ec4;&#x7ec7;PPIA&#x3001;43 kDa Tar DNA&#x7ed3;&#x5408;&#x86cb;&#x767d;&#xff08;TDP-43&#xff09;&#x3001;NF-&#x3ba;B&#x86cb;&#x767d;&#x76f8;&#x5bf9;&#x8868;&#x8fbe;&#x91cf;&#xff1b;&#x514d;&#x75ab;&#x7ec4;&#x7ec7;&#x5316;&#x5b66;&#x6cd5;&#x68c0;&#x6d4b;&#x5404;&#x7ec4;&#x5c0f;&#x9f20;&#x810a;&#x9ad3;&#x7ec4;&#x7ec7;TDP-43&#x9633;&#x6027;&#x8868;&#x8fbe;&#x6c34;&#x5e73;&#xff1b;&#x514d;&#x75ab;&#x8367;&#x5149;&#x6cd5;&#x68c0;&#x6d4b;&#x5404;&#x7ec4;&#x5c0f;&#x9f20;&#x810a;&#x9ad3;&#x7ec4;&#x7ec7;PPIA&#x9633;&#x6027;&#x8868;&#x8fbe;&#x6c34;&#x5e73;&#xff1b;ELISA&#x6cd5;&#x68c0;&#x6d4b;&#x5404;&#x7ec4;&#x5c0f;&#x9f20;&#x8840;&#x6e05;PPIA&#x542b;&#x91cf;&#x3002;<b>&#x7ed3;&#x679c;</b>: &#x4e0e;&#x7a7a;&#x767d;&#x7ec4;&#x6bd4;&#x8f83;&#xff0c;&#x6a21;&#x578b;&#x7ec4;&#x5c0f;&#x9f20;&#x6389;&#x68d2;&#x6f5c;&#x4f0f;&#x671f;&#x53ca;&#x65f7;&#x573a;&#x8fd0;&#x52a8;&#x603b;&#x8ddd;&#x79bb;&#x7f29;&#x77ed;&#xff08;<i>P</i>&lt;0.01&#xff09;&#xff0c;&#x810a;&#x9ad3;&#x524d;&#x89d2;&#x8fd0;&#x52a8;&#x795e;&#x7ecf;&#x5143;&#x6570;&#x91cf;&#x51cf;&#x5c11;&#xff0c;&#x7ec6;&#x80de;&#x5f62;&#x6001;&#x4e0d;&#x5b8c;&#x6574;&#xff0c;&#x80de;&#x4f53;&#x840e;&#x7f29;&#xff0c;TDP-43&#x86cb;&#x767d;&#x8868;&#x8fbe;&#x53ca;&#x9633;&#x6027;&#x8868;&#x8fbe;&#x5347;&#x9ad8;&#xff08;<i>P</i>&lt;0.01&#xff09;&#xff0c;PPIA&#x3001;NF-&#x3ba;B&#x86cb;&#x767d;&#x76f8;&#x5bf9;&#x8868;&#x8fbe;&#x91cf;&#x5347;&#x9ad8;&#xff08;<i>P</i>&lt;0.01&#xff09;&#xff0c;&#x8840;&#x6e05;PPIA&#x542b;&#x91cf;&#x53ca;&#x810a;&#x9ad3;&#x7ec4;&#x7ec7;PPIA&#x514d;&#x75ab;&#x8367;&#x5149;&#x8868;&#x8fbe;&#x5347;&#x9ad8;&#xff08;<i>P</i>&lt;0.01&#xff09;&#x3002;&#x4e0e;&#x6a21;&#x578b;&#x7ec4;&#x6bd4;&#x8f83;&#xff0c;&#x7535;&#x9488;&#x7ec4;&#x548c;&#x5229;&#x9c81;&#x5511;&#x7ec4;&#x5c0f;&#x9f20;&#x6389;&#x68d2;&#x6f5c;&#x4f0f;&#x671f;&#x3001;&#x65f7;&#x573a;&#x8fd0;&#x52a8;&#x603b;&#x8ddd;&#x79bb;&#x5ef6;&#x957f;&#xff08;<i>P</i>&lt;0.05&#xff0c;<i>P</i>&lt;0.01&#xff09;&#xff0c;&#x810a;&#x9ad3;&#x524d;&#x89d2;&#x8fd0;&#x52a8;&#x795e;&#x7ecf;&#x5143;&#x635f;&#x4f24;&#x51cf;&#x8f7b;&#xff0c;&#x810a;&#x9ad3;&#x7ec4;&#x7ec7;TDP-43&#x86cb;&#x767d;&#x8868;&#x8fbe;&#x53ca;&#x9633;&#x6027;&#x8868;&#x8fbe;&#x964d;&#x4f4e;&#xff08;<i>P</i>&lt;0.05&#xff0c;<i>P</i>&lt;0.01&#xff09;&#xff1b;&#x7535;&#x9488;&#x7ec4;&#x5c0f;&#x9f20;&#x810a;&#x9ad3;&#x7ec4;&#x7ec7;PPIA&#x3001;NF-&#x3ba;B&#x86cb;&#x767d;&#x76f8;&#x5bf9;&#x8868;&#x8fbe;&#x91cf;&#x964d;&#x4f4e;&#xff08;<i>P</i>&lt;0.05&#xff0c;<i>P</i>&lt;0.01&#xff09;&#xff0c;&#x8840;&#x6e05;PPIA&#x542b;&#x91cf;&#x53ca;&#x810a;&#x9ad3;&#x7ec4;&#x7ec7;PPIA&#x514d;&#x75ab;&#x8367;&#x5149;&#x8868;&#x8fbe;&#x964d;&#x4f4e;&#xff08;<i>P</i>&lt;0.05&#xff0c;<i>P</i>&lt;0.01&#xff09;&#xff1b;&#x5229;&#x9c81;&#x5511;&#x7ec4;&#x5c0f;&#x9f20;&#x810a;&#x9ad3;&#x7ec4;&#x7ec7;NF-&#x3ba;B&#x86cb;&#x767d;&#x76f8;&#x5bf9;&#x8868;&#x8fbe;&#x91cf;&#x53ca;PPIA&#x514d;&#x75ab;&#x8367;&#x5149;&#x8868;&#x8fbe;&#x964d;&#x4f4e;&#xff08;<i>P</i>&lt;0.05&#xff09;&#x3002;<b>&#x7ed3;&#x8bba;</b>: &#x7535;&#x9488;&#x5e72;&#x9884;&#x53ef;&#x6539;&#x5584;ALS&#x5c0f;&#x9f20;&#x8fd0;&#x52a8;&#x529f;&#x80fd;&#xff0c;&#x5176;&#x673a;&#x5236;&#x53ef;&#x80fd;&#x4e0e;&#x7535;&#x9488;&#x6291;&#x5236;PPIA/NF-&#x3ba;B&#x4fe1;&#x53f7;&#x901a;&#x8def;&#x8fdb;&#x800c;&#x7f13;&#x89e3;&#x795e;&#x7ecf;&#x708e;&#x6027;&#x53cd;&#x5e94;&#x6709;&#x5173;&#x3002;.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Electroacupuncture</Keyword><Keyword MajorTopicYN="N">Extracellular cyclophilin A</Keyword><Keyword MajorTopicYN="N">Nuclear factor-&#x3ba;B</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>26</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>25</Day><Hour>21</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37879951</ArticleId><ArticleId IdType="doi">10.13702/j.1000-0607.20230251</ArticleId><ArticleId IdType="pii">1000-0607(2023)10-1009-08</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>&#x5f20;&#x82b3; &#xff0c; &#x738b;&#x6653;&#x826f;. &#x8840;&#x6db2;&#x8f7d;&#x8102;&#x86cb;&#x767d;&#x4f5c;&#x4e3a;&#x795e;&#x7ecf;&#x9000;&#x884c;&#x6027;&#x75be;&#x75c5;&#x6f5c;&#x5728;&#x751f;&#x7269;&#x6807;&#x5fd7;&#x7269;&#x7684;&#x7814;&#x7a76; &#xff3b;J&#xff3d;. &#x836f;&#x5b66;&#x5b66;&#x62a5; &#xff0c; 2021 &#xff0c; 56 &#xff08; 6 &#xff09;&#xff1a; 1513- 1520.</Citation></Reference><Reference><Citation>VAN ES M A &#xff0c; HARDIMAN O &#xff0c; CHIO A &#xff0c; et al. Amyotrophic lateral sclerosis &#xff3b;J&#xff3d;. Lancet &#xff0c; 2017 &#xff0c; 390 &#xff08; 10107 &#xff09;&#xff1a; 2084- 2098.</Citation></Reference><Reference><Citation>&#x9ec4;&#x5b97;&#x6656; &#xff0c; &#x5468;&#x8363;&#x658c;. &#x795e;&#x7ecf;&#x708e;&#x75c7;&#x4e0e;&#x795e;&#x7ecf;&#x9000;&#x884c;&#x6027;&#x75be;&#x75c5; &#xff3b;J&#xff3d;. &#x79d1;&#x6280;&#x5bfc;&#x62a5; &#xff0c; 2021 &#xff0c; 39 &#xff08; 20 &#xff09;&#xff1a; 45- 55.</Citation></Reference><Reference><Citation>GALL L L &#xff0c; ANAKOR E &#xff0c; CONNOLLY O &#xff0c; et al. Molecular and cellular mechanisms affected in ALS &#xff3b;J&#xff3d;. J Pers Med &#xff0c; 2020 &#xff0c; 10 &#xff08; 3 &#xff09;&#xff1a; 101.</Citation></Reference><Reference><Citation>PASETTO L &#xff0c; POZZI S &#xff0c; CASTELNOVO M &#xff0c; et al. Targeting extracellular cyclophilin A reduces neuroinflammation and extends survival in a mouse model of amyotrophic lateral sclerosis &#xff3b;J&#xff3d;. J Neurosci &#xff0c; 2017 &#xff0c; 37 &#xff08; 6 &#xff09;&#xff1a; 1413- 1427.</Citation></Reference><Reference><Citation>&#x5b59;&#x8fdc;&#x5f81; &#xff0c; &#x8d75;&#x5e7f;&#x7136; &#xff0c; &#x5218;&#x5f66;&#x9e9f; &#xff0c; &#x7b49;. &#x9488;&#x523a;&#x901a;&#x8fc7;&#x5f71;&#x54cd;TLR4-NF-&#x3ba;B&#x4fe1;&#x53f7;&#x901a;&#x8def;&#x5728;&#x6cbb;&#x7597;&#x6162;&#x6027;&#x795e;&#x7ecf;&#x9000;&#x884c;&#x6027;&#x75be;&#x75c5;&#x4e2d;&#x7684;&#x4f5c;&#x7528; &#xff3b;J&#xff3d;. &#x9488;&#x7078;&#x4e34;&#x5e8a;&#x6742;&#x5fd7; &#xff0c; 2021 &#xff0c; 37 &#xff08; 4 &#xff09;&#xff1a; 102- 107.</Citation></Reference><Reference><Citation>&#x9a6c;&#x817e; &#xff0c; &#x9ec4;&#x94f6;&#x5170; &#xff0c; &#x674e;&#x73b2; &#xff0c; &#x7b49;. &#x9488;&#x523a;&#x9633;&#x660e;&#x7ecf;&#x7a74;&#x5bf9;&#x5bb6;&#x65cf;&#x6027;&#x808c;&#x840e;&#x7f29;&#x4fa7;&#x7d22;&#x786c;&#x5316;&#x75c7;&#x60a3;&#x8005;&#x795e;&#x7ecf;&#x529f;&#x80fd;&#x53ca;&#x808c;&#x7535;&#x56fe;&#x7684;&#x5f71;&#x54cd; &#xff3b;J&#xff3d;. &#x65f6;&#x73cd;&#x56fd;&#x533b;&#x56fd;&#x836f; &#xff0c; 2016 &#xff0c; 27 &#xff08; 7 &#xff09;&#xff1a; 1770- 1771.</Citation></Reference><Reference><Citation>&#x5b5f;&#x658c; &#xff0c; &#x7530;&#x9756;. &#x201c;&#x901a;&#x7763;&#x6e29;&#x9633;&#x201d;&#x6cd5;&#x9488;&#x523a;&#x6cbb;&#x7597;&#x808c;&#x840e;&#x7f29;&#x4fa7;&#x7d22;&#x786c;&#x5316;&#x75c7;&#x4e34;&#x5e8a;&#x89c2;&#x5bdf; &#xff3b;J&#xff3d;. &#x4e0a;&#x6d77;&#x9488;&#x7078;&#x6742;&#x5fd7; &#xff0c; 2017 &#xff0c; 36 &#xff08; 2 &#xff09;&#xff1a; 134- 137.</Citation></Reference><Reference><Citation>&#x536b;&#x5f66; &#xff0c; &#x6731;&#x4e45;&#x5b87; &#xff0c; &#x5bc7;&#x5409;&#x53cb; &#xff0c; &#x7b49;. &#x7535;&#x9488;&#x5939;&#x810a;&#x7a74;&#x914d;&#x5408;&#x827e;&#x7078;&#x6cbb;&#x7597;&#x808c;&#x840e;&#x7f29;&#x4fa7;&#x7d22;&#x786c;&#x5316;17&#x4f8b; &#xff3b;J&#xff3d;. &#x4e2d;&#x56fd;&#x9488;&#x7078; &#xff0c; 2018 &#xff0c; 38 &#xff08; 6 &#xff09;&#xff1a; 613- 615.</Citation></Reference><Reference><Citation>&#x674e;&#x5fe0;&#x4ec1;. &#x5b9e;&#x9a8c;&#x9488;&#x7078;&#x5b66; &#xff3b;M&#xff3d;. 2&#x7248;. &#x5317;&#x4eac; &#xff1a; &#x4e2d;&#x56fd;&#x4e2d;&#x533b;&#x836f;&#x51fa;&#x7248;&#x793e; &#xff0c; 2007 &#xff1a; 242- 314.</Citation></Reference><Reference><Citation>ANDERSEN P M &#xff0c; BORASIO G D &#xff0c; DENGLER R &#xff0c; et al. Good practice in the management of amyotrophic lateral sclerosis&#xff1a; clinical guidelines. An evidence-based review with good practice points. EALSC Working Group &#xff3b;J&#xff3d;. Amyotroph Lateral Scler &#xff0c; 2007 &#xff0c; 8 &#xff08; 4 &#xff09;&#xff1a; 195- 213.</Citation></Reference><Reference><Citation>&#x90dc;&#x6587;&#x971e; &#xff0c; &#x5f90;&#x4e16;&#x82ac;. &#x5f90;&#x4e16;&#x82ac;&#x9488;&#x7078;&#x6cbb;&#x7597;&#x8fd0;&#x52a8;&#x795e;&#x7ecf;&#x5143;&#x75c5;&#x7ecf;&#x9a8c;&#x8f91;&#x8981; &#xff3b;J&#xff3d;. &#x56db;&#x5ddd;&#x4e2d;&#x533b; &#xff0c; 2016 &#xff0c; 34 &#xff08; 3 &#xff09;&#xff1a; 16- 18.</Citation></Reference><Reference><Citation>&#x674e;&#x9e3f;&#x6d69;. &#x4e2d;&#x533b;&#x9488;&#x7078;&#x5728;&#x808c;&#x840e;&#x7f29;&#x4fa7;&#x7d22;&#x786c;&#x5316;&#x75c7;&#x6cbb;&#x7597;&#x4e2d;&#x7684;&#x7814;&#x7a76;&#x8fdb;&#x5c55; &#xff3b;J&#xff3d;. &#x4e2d;&#x56fd;&#x5904;&#x65b9;&#x836f; &#xff0c; 2018 &#xff0c; 16 &#xff08; 8 &#xff09;&#xff1a; 28- 29.</Citation></Reference><Reference><Citation>&#x90ed;&#x5a55; &#xff0c; &#x8d75;&#x9896;&#x5029; &#xff0c; &#x674e;&#x534e; &#xff0c; &#x7b49;. &#x7535;&#x9488;&#x5bf9;&#x5e15;&#x91d1;&#x68ee;&#x75c5;&#x75f4;&#x5446;&#x5c0f;&#x9f20;&#x6d77;&#x9a6c;&#x7a81;&#x89e6;&#x53ef;&#x5851;&#x6027;&#x548c;&#x8865;&#x4f53;&#x4f9d;&#x8d56;&#x6027;&#x8bb0;&#x5fc6;&#x969c;&#x788d;&#x7684;&#x5f71;&#x54cd; &#xff3b;J&#xff3d;. &#x9488;&#x523a;&#x7814;&#x7a76; &#xff0c; 2022 &#xff0c; 47 &#xff08; 12 &#xff09;&#xff1a; 1041- 1047.</Citation></Reference><Reference><Citation>&#x738b;&#x4ed5;&#x6797; &#xff0c; &#x5b59;&#x8fdc;&#x5f81; &#xff0c; &#x4e8e;&#x5929;&#x6d0b; &#xff0c; &#x7b49;. &#x5939;&#x810a;&#x7535;&#x9488;&#x4e0d;&#x540c;&#x65f6;&#x95f4;&#x70b9;&#x5e72;&#x9884;&#x5bf9;ALS-SOD1<sup>G93A</sup>&#x5c0f;&#x9f20;&#x8170;&#x9ad3;TLR4/NF-&#x3ba;B&#x4fe1;&#x53f7;&#x901a;&#x8def;&#x7684;&#x5f71;&#x54cd; &#xff3b;J&#xff3d;. &#x9488;&#x7078;&#x4e34;&#x5e8a;&#x6742;&#x5fd7; &#xff0c; 2022 &#xff0c; 38 &#xff08; 6 &#xff09;&#xff1a; 56- 62.</Citation></Reference><Reference><Citation>CHAE Y &#xff0c; LEE H &#xff0c; KIM H &#xff0c; et al. Parsing brain activity associated with acupuncture treatment in Parkinson&#x2019;s diseases &#xff3b;J&#xff3d;. Mov Disord &#xff0c; 2009 &#xff0c; 24 &#xff08; 12 &#xff09;&#xff1a; 1794- 1802.</Citation></Reference><Reference><Citation>&#x90ed;&#x9896; &#xff0c; &#x795d;&#x9e4f;&#x5b87; &#xff0c; &#x5b59;&#x9896;&#x54f2; &#xff0c; &#x7b49;. &#x5939;&#x810a;&#x7535;&#x9488;&#x5bf9;ALS-SOD1<sup>G93A</sup>&#x8f6c;&#x57fa;&#x56e0;&#x5c0f;&#x9f20;&#x8170;&#x9ad3;&#x524d;&#x89d2;&#x8fd0;&#x52a8;&#x795e;&#x7ecf;&#x5143;&#x5f62;&#x6001;&#x5b66;&#x7684;&#x5f71;&#x54cd; &#xff3b;J&#xff3d;. &#x9488;&#x7078;&#x4e34;&#x5e8a;&#x6742;&#x5fd7; &#xff0c; 2017 &#xff0c; 33 &#xff08; 5 &#xff09;&#xff1a; 60- 64&#xff0c; 89.</Citation></Reference><Reference><Citation>SMETHURST P &#xff0c; NEWCOMBE J &#xff0c; TROAKES C &#xff0c; et al. <i>In vitro</i> prion-like behaviour of TDP-43 in ALS &#xff3b;J&#xff3d;. Neurobiol Dis &#xff0c; 2016 &#xff0c; 96 &#xff1a; 236- 247.</Citation></Reference><Reference><Citation>GUO L &#xff0c; SHORTER J. Biology and pathobiology of TDP-43 and emergent therapeutic strategies &#xff3b;J&#xff3d;. Cold Spring Harb Perspect Med &#xff0c; 2017 &#xff0c; 7 &#xff08; 9 &#xff09;&#xff1a; a024554.</Citation></Reference><Reference><Citation>&#x9ec4;&#x8302;&#x946b; &#xff0c; &#x5ec9;&#x5b8f;&#x60f3; &#xff0c; &#x738b;&#x4fca;&#x5cad;. TDP-43&#x53c2;&#x4e0e;&#x808c;&#x840e;&#x7f29;&#x4fa7;&#x7d22;&#x786c;&#x5316;&#x75c7;&#x7684;&#x75c5;&#x7406;&#x673a;&#x5236;&#x7814;&#x7a76;&#x8fdb;&#x5c55; &#xff3b;J&#xff3d;. &#x4e34;&#x5e8a;&#x4e0e;&#x75c5;&#x7406;&#x6742;&#x5fd7; &#xff0c; 2021 &#xff0c; 41 &#xff08; 7 &#xff09;&#xff1a; 1665- 1673.</Citation></Reference><Reference><Citation>SU&#xc1;REZ-CALVET M &#xff0c; DOLS-ICARDO O &#xff0c; LLAD&#xd3; A &#xff0c; et al. Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation &#xff3b;J&#xff3d;. J Neurol Neurosurg Psychiatry &#xff0c; 2014 &#xff0c; 85 &#xff08; 6 &#xff09;&#xff1a; 684- 691.</Citation></Reference><Reference><Citation>FENEBERG E &#xff0c; GRAY E &#xff0c; ANSORGE O &#xff0c; et al. Towards a TDP-43-based biomarker for ALS and FTLD &#xff3b;J&#xff3d;. Mol Neurobiol &#xff0c; 2018 &#xff0c; 55 &#xff08; 10 &#xff09;&#xff1a; 7789- 7801.</Citation></Reference><Reference><Citation>WANG P &#xff0c; HEITMAN J. The cyclophilins &#xff3b;J&#xff3d;. Genome Biol &#xff0c; 2005 &#xff0c; 6 &#xff08; 7 &#xff09;&#xff1a; 226.</Citation></Reference><Reference><Citation>KOLETSKY A J &#xff0c; HARDING M W &#xff0c; HANDSCHUMA CHER R E. Cyclophilin&#xff1a; distribution and variant properties in normal and neoplastic tissues &#xff3b;J&#xff3d;. J Immunol &#xff0c; 1986 &#xff0c; 137 &#xff08; 3 &#xff09;&#xff1a; 1054- 1059.</Citation></Reference><Reference><Citation>ANSARI H &#xff0c; GRECO G &#xff0c; LUBAN J. Cyclophilin A peptidyl-prolyl isomerase activity promotes ZPR1 nuclear export &#xff3b;J&#xff3d;. Mol Cell Biol &#xff0c; 2002 &#xff0c; 22 &#xff08; 20 &#xff09;&#xff1a; 6993- 7003.</Citation></Reference><Reference><Citation>ABDULLAH A A &#xff0c; ABDULLAH R &#xff0c; NAZARIAH Z A &#xff0c; et al. Cyclophilin A as a target in the treatment of cytomegalovirus infections &#xff3b;J&#xff3d;. Antivir Chem Chemother &#xff0c; 2018 &#xff0c; 26 &#xff1a; 2040206618811413.</Citation></Reference><Reference><Citation>DEAR J W &#xff0c; LEELAHAVANICHKUL A &#xff0c; APONTE A &#xff0c; et al. Liver proteomics for therapeutic drug discovery&#xff1a; inhibition of the cyclophilin receptor CD147 attenuates sepsis-induced acute renal failure &#xff3b;J&#xff3d;. Crit Care Med &#xff0c; 2007 &#xff0c; 35 &#xff08; 10 &#xff09;&#xff1a; 2319- 2328.</Citation></Reference><Reference><Citation>TEGEDER I &#xff0c; SCHUMACHER A &#xff0c; JOHN S &#xff0c; et al. Ele-vated serum cyclophilin levels in patients with severe sepsis &#xff3b;J&#xff3d;. J Clin Immunol &#xff0c; 1997 &#xff0c; 17 &#xff08; 5 &#xff09;&#xff1a; 380- 386.</Citation></Reference><Reference><Citation>COPPINGER J A &#xff0c; CAGNEY G &#xff0c; TOOMEY S &#xff0c; et al. Cha-racterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions &#xff3b;J&#xff3d;. Blood &#xff0c; 2004 &#xff0c; 103 &#xff08; 6 &#xff09;&#xff1a; 2096- 2104.</Citation></Reference><Reference><Citation>HARIGAI M &#xff0c; HARA M &#xff0c; TAKAHASHI N &#xff0c; et al. Presence of autoantibodies to peptidyl-prolyl cis-trans isomerase &#xff08;Cyclosporin A-binding protein&#xff09; in systemic lupus erythematosus &#xff3b;J&#xff3d;. Clin Immunol Immunopathol &#xff0c; 1992 &#xff0c; 63 &#xff08; 1 &#xff09;&#xff1a; 58- 65.</Citation></Reference><Reference><Citation>MASSIGNAN T &#xff0c; CASONI F &#xff0c; BASSO M &#xff0c; et al. Proteomic analysis of spinal cord of presymptomatic amyotrophic lateral sclerosis G93A SOD1 mouse &#xff3b;J&#xff3d;. Biochem Biophys Res Commun &#xff0c; 2007 &#xff0c; 353 &#xff08; 3 &#xff09;&#xff1a; 719- 725.</Citation></Reference><Reference><Citation>&#x6768;&#x5a77; &#xff0c; &#x9ec4;&#x4e16;&#x5149;. &#x4eb2;&#x73af;&#x86cb;&#x767d;A&#x4e0e;CD147&#x7684;&#x76f8;&#x4e92;&#x4f5c;&#x7528;&#x53ca;&#x5176;&#x5728;&#x7259;&#x5468;&#x708e;&#x4e2d;&#x7684;&#x610f;&#x4e49; &#xff3b;J&#xff3d;. &#x53e3;&#x8154;&#x75be;&#x75c5;&#x9632;&#x6cbb; &#xff0c; 2021 &#xff0c; 29 &#xff08; 3 &#xff09;&#xff1a; 189- 193.</Citation></Reference><Reference><Citation>CHENG F Y &#xff0c; YUAN W &#xff0c; CAO M F &#xff0c; et al. Cyclophilin A protects cardiomyocytes against hypoxia/reoxygenation-induced apoptosis via the AKT/Nox2 pathway &#xff3b;J&#xff3d;. Oxid Med Cell Longev &#xff0c; 2019 &#xff0c; 2019 &#xff1a; 2717986.</Citation></Reference><Reference><Citation>DAWAR F U &#xff0c; XIONG Y &#xff0c; KHATTAK M N K &#xff0c; et al. Potential role of cyclophilin A in regulating cytokine secretion &#xff3b;J&#xff3d;. J Leukoc Biol &#xff0c; 2017 &#xff0c; 102 &#xff08; 4 &#xff09;&#xff1a; 989- 992.</Citation></Reference><Reference><Citation>BELL R D &#xff0c; WINKLER E A &#xff0c; SINGH I &#xff0c; et al. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A &#xff3b;J&#xff3d;. Nature &#xff0c; 2012 &#xff0c; 485 &#xff08; 7399 &#xff09;&#xff1a; 512- 516.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>